Artgen Biotech PJSC (MOEX:ISKJ)
Russia · Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Balance Sheet
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 752.18 | 565.37 | 503.35 | 544.94 | 201.66 | 193.29 |
Trading Asset Securities | 79.41 | 165.12 | 35.11 | 27.39 | 25.4 | 0.51 |
Cash & Short-Term Investments | 831.59 | 730.49 | 538.46 | 572.33 | 227.06 | 193.8 |
Cash Growth | 104.38% | 35.66% | -5.92% | 152.07% | 17.16% | 79.61% |
Accounts Receivable | 124.51 | 83.66 | 67.3 | 81.83 | 67.86 | 83.2 |
Other Receivables | 111.97 | 80.35 | 52.33 | 72.58 | 61.69 | 23.92 |
Receivables | 528.37 | 380.11 | 189.6 | 205.38 | 185.11 | 131.76 |
Inventory | 187.37 | 177.78 | 207.95 | 226.31 | 223.87 | 245.79 |
Other Current Assets | 120.42 | 102.04 | 97.94 | 113.22 | 53.74 | 86.71 |
Total Current Assets | 1,668 | 1,390 | 1,034 | 1,117 | 689.77 | 658.06 |
Property, Plant & Equipment | 409.04 | 374.98 | 376.86 | 315.87 | 280.51 | 285 |
Long-Term Investments | 158.56 | 85.32 | 96.91 | 161.33 | 193.34 | 120.62 |
Other Intangible Assets | 428.38 | 324.43 | 347.92 | 174.9 | 150.1 | 128.6 |
Long-Term Deferred Tax Assets | 156.53 | 138.21 | 115.23 | 90.83 | 83.03 | 86.12 |
Long-Term Deferred Charges | 450.54 | 556.71 | 510.21 | 631.35 | 586.62 | 414.09 |
Total Assets | 3,459 | 2,988 | 2,633 | 2,544 | 2,045 | 1,737 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 68.39 | 41.96 | 54.92 | 53.41 | 33.87 | 35.94 |
Short-Term Debt | - | - | - | 0.73 | 0.73 | 0.2 |
Current Portion of Long-Term Debt | 391.39 | 398.65 | 87.71 | 219.72 | 106.44 | - |
Current Portion of Leases | 24.47 | 27.08 | 25.17 | 19.53 | 11.69 | 8.89 |
Current Income Taxes Payable | 34.94 | 23.38 | 15 | 24.84 | 24.57 | 14.61 |
Other Current Liabilities | 416.64 | 285.42 | 286.11 | 243.16 | 218.28 | 312.52 |
Total Current Liabilities | 935.84 | 776.49 | 468.91 | 561.4 | 395.57 | 372.15 |
Long-Term Debt | 434.31 | 422.41 | 480.5 | 427.2 | 601.38 | 494.23 |
Long-Term Leases | 153.61 | 116.85 | 144.28 | 119.77 | 111.36 | 113.82 |
Other Long-Term Liabilities | 510.5 | 530.69 | 504.13 | 460.96 | 366 | 296.49 |
Total Liabilities | 2,034 | 1,846 | 1,598 | 1,569 | 1,474 | 1,277 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 9.27 | 9.27 | 9.27 | 9.27 | 9.27 | 8.5 |
Additional Paid-In Capital | 638.99 | 638.99 | 626.58 | 625.13 | 612.1 | 567.43 |
Retained Earnings | 353.23 | 424.4 | 326.53 | 241.53 | 146.45 | 94.13 |
Treasury Stock | -497.82 | -497.68 | -499.39 | -421.99 | -447.85 | -446.98 |
Comprehensive Income & Other | -95.11 | -101.21 | -94.51 | -30.06 | 21.07 | 11.7 |
Total Common Equity | 408.57 | 473.77 | 368.47 | 423.87 | 341.04 | 234.78 |
Minority Interest | 1,016 | 667.52 | 666.25 | 550.86 | 229.22 | 225.78 |
Shareholders' Equity | 1,425 | 1,141 | 1,035 | 974.73 | 570.26 | 460.56 |
Total Liabilities & Equity | 3,459 | 2,988 | 2,633 | 2,544 | 2,045 | 1,737 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,004 | 964.99 | 737.65 | 786.96 | 831.6 | 617.13 |
Net Cash (Debt) | -172.19 | -234.5 | -199.2 | -214.62 | -604.55 | -423.33 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.31 | -3.12 | -2.68 | -2.32 | -6.96 | -5.29 |
Filing Date Shares Outstanding | 73.9 | 73.9 | 73.76 | 75.15 | 81.61 | 85 |
Total Common Shares Outstanding | 73.9 | 73.9 | 73.76 | 75.15 | 81.61 | 85 |
Working Capital | 731.91 | 613.93 | 565.04 | 555.84 | 294.2 | 285.9 |
Book Value Per Share | 5.53 | 6.41 | 5.00 | 5.64 | 4.18 | 2.76 |
Tangible Book Value | -19.82 | 149.34 | 20.55 | 248.97 | 190.94 | 106.18 |
Tangible Book Value Per Share | -0.27 | 2.02 | 0.28 | 3.31 | 2.34 | 1.25 |
Buildings | 52.99 | 59.88 | 63.02 | 67.06 | 49.65 | 97.89 |
Machinery | 456.83 | 437.55 | 419.13 | 375.42 | 353.72 | 336.45 |
Construction In Progress | 56.17 | 55.32 | 16.15 | - | - | 0.05 |